129 related articles for article (PubMed ID: 16648578)
1. Organ-specific expression profiles of rat mammary gland, liver, and lung tissues treated with targretin, 9-cis retinoic acid, and 4-hydroxyphenylretinamide.
Wang Y; Yao R; Maciag A; Grubbs CJ; Lubet RA; You M
Mol Cancer Ther; 2006 Apr; 5(4):1060-72. PubMed ID: 16648578
[TBL] [Abstract][Full Text] [Related]
2. Effects of retinoid treatment of rats on hepatic microsomal metabolism and cytochromes P450. Correlation between retinoic acid receptor/retinoid x receptor selectivity and effects on metabolic enzymes.
Howell SR; Shirley MA; Ulm EH
Drug Metab Dispos; 1998 Mar; 26(3):234-9. PubMed ID: 9492386
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
Grubbs CJ; Lubet RA; Atigadda VR; Christov K; Deshpande AM; Tirmal V; Xia G; Bland KI; Eto I; Brouillette WJ; Muccio DD
Carcinogenesis; 2006 Jun; 27(6):1232-9. PubMed ID: 16344269
[TBL] [Abstract][Full Text] [Related]
4. Effects on gene expression in rat liver after administration of RXR agonists: UAB30, 4-methyl-UAB30, and Targretin (Bexarotene).
Vedell PT; Lu Y; Grubbs CJ; Yin Y; Jiang H; Bland KI; Muccio DD; Cvetkovic D; You M; Lubet R
Mol Pharmacol; 2013 Mar; 83(3):698-708. PubMed ID: 23292798
[TBL] [Abstract][Full Text] [Related]
5. The rexinoid, bexarotene, prevents the development of premalignant lesions in MMTV-erbB2 mice.
Li Y; Zhang Y; Hill J; Kim HT; Shen Q; Bissonnette RP; Lamph WW; Brown PH
Br J Cancer; 2008 Apr; 98(8):1380-8. PubMed ID: 18362934
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.
Gottardis MM; Bischoff ED; Shirley MA; Wagoner MA; Lamph WW; Heyman RA
Cancer Res; 1996 Dec; 56(24):5566-70. PubMed ID: 8971154
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of a retinoid X receptor-selective ligand bexarotene (LGD1069, Targretin) and paclitaxel (Taxol) in mammary carcinoma.
Yen WC; Prudente RY; Lamph WW
Breast Cancer Res Treat; 2004 Nov; 88(2):141-8. PubMed ID: 15564797
[TBL] [Abstract][Full Text] [Related]
8. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
Mehta RG; Williamson E; Patel MK; Koeffler HP
J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
[TBL] [Abstract][Full Text] [Related]
9. Identification of biomarkers modulated by the rexinoid LGD1069 (bexarotene) in human breast cells using oligonucleotide arrays.
Kim HT; Kong G; Denardo D; Li Y; Uray I; Pal S; Mohsin S; Hilsenbeck SG; Bissonnette R; Lamph WW; Johnson K; Brown PH
Cancer Res; 2006 Dec; 66(24):12009-18. PubMed ID: 17178900
[TBL] [Abstract][Full Text] [Related]
10. Bexarotene ligand pharmaceuticals.
Hurst RE
Curr Opin Investig Drugs; 2000 Dec; 1(4):514-23. PubMed ID: 11249708
[TBL] [Abstract][Full Text] [Related]
11. 9-cis-Retinoic acid suppresses mammary tumorigenesis in C3(1)-simian virus 40 T antigen-transgenic mice.
Wu K; Kim HT; Rodriquez JL; Munoz-Medellin D; Mohsin SK; Hilsenbeck SG; Lamph WW; Gottardis MM; Shirley MA; Kuhn JG; Green JE; Brown PH
Clin Cancer Res; 2000 Sep; 6(9):3696-704. PubMed ID: 10999763
[TBL] [Abstract][Full Text] [Related]
12. Neu-induced retroviral rat mammary carcinogenesis: a novel chemoprevention model for both hormonally responsive and nonresponsive mammary carcinomas.
Woditschka S; Haag JD; Waller JL; Monson DM; Hitt AA; Brose HL; Hu R; Zheng Y; Watson PA; Kim K; Lindstrom MJ; Mau B; Steele VE; Lubet RA; Gould MN
Cancer Res; 2006 Jul; 66(13):6884-91. PubMed ID: 16818667
[TBL] [Abstract][Full Text] [Related]
13. Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells.
Kim MS; Lim DY; Kim JE; Chen H; Lubet RA; Dong Z; Bode AM
Mol Carcinog; 2015 Dec; 54(12):1596-604. PubMed ID: 25328014
[TBL] [Abstract][Full Text] [Related]
14. Prevention of mouse lung tumors by targretin.
Pereira MA; Kramer PM; Nines R; Liu Y; Alyaqoub FS; Gunning WT; Steele VE; Lubet RA
Int J Cancer; 2006 May; 118(9):2359-62. PubMed ID: 16331605
[TBL] [Abstract][Full Text] [Related]
15. Energy status regulates levels of the RAR/RXR ligand 9-cis-retinoic acid in mammalian tissues: Glucose reduces its synthesis in β-cells.
Yoo HS; Moss KO; Cockrum MA; Woo W; Napoli JL
J Biol Chem; 2023 Oct; 299(10):105255. PubMed ID: 37714463
[TBL] [Abstract][Full Text] [Related]
16. 9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2.
Mernitz H; Smith DE; Zhu AX; Wang XD
Cancer Lett; 2006 Nov; 244(1):101-8. PubMed ID: 16413115
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis.
Lubet RA; Christov K; Nunez NP; Hursting SD; Steele VE; Juliana MM; Eto I; Grubbs CJ
Carcinogenesis; 2005 Feb; 26(2):441-8. PubMed ID: 15591091
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of human in vitro and mouse in vitro and in vivo mammary tumor models by retinoids in comparison with tamoxifen and the RU-486 anti-progestagen.
Darro F; Cahen P; Vianna A; Decaestecker C; Nogaret JM; Leblond B; Chaboteaux C; Ramos C; Pétein M; Budel V; Schoofs A; Pourrias B; Kiss R
Breast Cancer Res Treat; 1998 Sep; 51(1):39-55. PubMed ID: 9877028
[TBL] [Abstract][Full Text] [Related]
19. Induction of adipocyte-specific gene expression is correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (targretin).
Agarwal VR; Bischoff ED; Hermann T; Lamph WW
Cancer Res; 2000 Nov; 60(21):6033-8. PubMed ID: 11085524
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of transforming growth factor-alpha/epidermal growth factor receptor autocrine signaling by an RXR-selective retinoid (LGD1069, Targretin) in head and neck cancer cell lines.
Song JI; Lango MN; Hwang JD; Drenning SD; Zeng Q; Lamph WW; Grandis JR
Cancer Res; 2001 Aug; 61(15):5919-25. PubMed ID: 11479234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
